Literature DB >> 7418713

Pharmacokinetics of acebutolol in patients with all grades of renal failure.

A Roux, P Aubert, J Guedon, B Flouvat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7418713     DOI： 10.1007/bf00558446

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  34 in total

1.  [Spectrofluorometric determination of a new beta-blocking agent, acebutolol in blood and urine].

Authors:  A Roux; B Flouvat; P Delaveau
Journal:  Ann Biol Clin (Paris)       Date:  1975       Impact factor: 0.459

2.  A study of practolol elimination in all grades of chronic renal failure.

Authors:  C M Kaye; C R Kumana; D A Franklin; L R Baker
Journal:  Int J Clin Pharmacol Biopharm       Date:  1975-07

3.  Relationship between renal function and elimination kinetics of pindolol in man.

Authors:  S Oie; G Levy
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

4.  [Study of the binding of beta blockers to plasma proteins. Therapeutic consequences].

Authors:  S Decourt; A Roux; A Baglin; M Domart; P Aubert; B Flouvat; D Fritel
Journal:  Acquis Med Recent       Date:  1977

5.  Pharmacokinetics of oral propranolol in chronic renal disease.

Authors:  D T Lowenthal; W A Briggs; T P Gibson; H Nelson; W J Cirksena
Journal:  Clin Pharmacol Ther       Date:  1974-11       Impact factor: 6.875

6.  Pentazocine binding to blood cells and plasma proteins.

Authors:  M Ehrnebo; S Agurell; L O Boréus; E Gordon; U Lönroth
Journal:  Clin Pharmacol Ther       Date:  1974-09       Impact factor: 6.875

7.  Pharmacodynamics of practolol in chronic renal failure.

Authors:  J B Eastwood; J R Curtis; R B Smith
Journal:  Br Med J       Date:  1973-11-10

8.  Plasma propranolol levels in adults with observations in four children.

Authors:  D G Shand; E M Nuckolls; J A Oates
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.875

9.  Acebutolol metabolite plasma concentration during chronic oral therapy.

Authors:  R A Winkle; P J Meffin; W B Ricks; D C Harrison
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

10.  [Study of acebutolol dialysis and pharmacokinetic data in patients with renal insufficiency undergoing hemodialysis].

Authors:  A Roux; P Aubert; J Guédon; B Flouvat
Journal:  Nouv Presse Med       Date:  1975-12-31
View more
  14 in total

1.  Pharmacokinetics of torasemide and its metabolites in healthy controls and in chronic renal failure.

Authors:  H Spahn; H Knauf; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  β-Blocker dialyzability and mortality in older patients receiving hemodialysis.

Authors:  Matthew A Weir; Stephanie N Dixon; Jamie L Fleet; Matthew A Roberts; Daniel G Hackam; Matthew J Oliver; Rita S Suri; Robert R Quinn; Sundus Ozair; Michael M Beyea; Abhijat Kitchlu; Amit X Garg
Journal:  J Am Soc Nephrol       Date:  2014-10-30       Impact factor: 10.121

3.  To nurse when receiving acebutolol: is it dangerous for the neonate?

Authors:  M J Boutroy; G Bianchetti; C Dubruc; P Vert; P L Morselli
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 4.  Drug metabolites in renal failure: pharmacokinetic and clinical implications.

Authors:  R K Verbeeck; R A Branch; G R Wilkinson
Journal:  Clin Pharmacokinet       Date:  1981 Sep-Oct       Impact factor: 6.447

5.  Pharmacokinetics and bioavailability of diacetolol, the main metabolite of acebutolol.

Authors:  B Flouvat; A Roux; N P Chau; M Viallet; X Andre-Fouet; R Woehrle; J Gregoire
Journal:  Eur J Clin Pharmacol       Date:  1981-03       Impact factor: 2.953

Review 6.  The loop diuretic torasemide in chronic renal failure. Pharmacokinetics and pharmacodynamics.

Authors:  H Knauf; H Spahn; E Mutschler
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 7.  Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.

Authors:  B N Singh; W R Thoden; A Ward
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

8.  Pharmacokinetics in man of acebutolol and hydrochlorothiazide as single agents and in combination.

Authors:  A Roux; A Le Liboux; B Delhotal; J Gaillot; B Flouvat
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

9.  Acebutolol pharmacokinetics in renal failure.

Authors:  R S Smith; D J Warren; A G Renwick; C F George
Journal:  Br J Clin Pharmacol       Date:  1983-09       Impact factor: 4.335

Review 10.  Metabolites of antihypertensive drugs. An updated review of their clinical pharmacokinetic and therapeutic implications.

Authors:  A Ebihara; A Fujimura
Journal:  Clin Pharmacokinet       Date:  1991-11       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.